Status:
NOT_YET_RECRUITING
Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2
Lead Sponsor:
Boston University Charles River Campus
Collaborating Sponsors:
University of Witwatersrand, South Africa
Massachusetts General Hospital
Conditions:
Cervical Cancer
Hiv
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The investigators will conduct the formative work that is necessary to develop a novel, multi-level intervention (inclusive of patient- and provider-level components), which will increase awareness of...
Eligibility Criteria
Inclusion
- Having a cervix
- Aged 18+
- Living with HIV
- Recent high-risk abnormal Pap results within the last month (if needed, we may increase the range by up to 6 months to ensure that we meet our targets).
Exclusion
- Younger than 18 years old
- HIV-negative
- No cervix/history of hysterectomy
- Recent normal or low-risk abnormal Pap results
- Unable to provide informed consent or assent in English or isiZulu and/or have a significant psychiatric illness (e.g., active psychotic disorder or untreated bipolar disorder) that could interfere with participation will be excluded. Potential participants will also be asked if they have any health conditions that make it difficult for them to travel to the clinic.
Key Trial Info
Start Date :
October 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06182241
Start Date
October 15 2025
End Date
May 31 2026
Last Update
September 19 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
2
Boston University
Boston, Massachusetts, United States, 02215
3
MatCH Research Unit (MRU), a Division of the Wits Health Consortium, University of Witwatersrand
Durban, KwaZulu-Natal, South Africa, 4000